Iranian Journal of Parasitology 2017. 12(4):587-596.

Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice
Atef HUSSEIN, Samia RASHED, Ibrahim El HAYAWAN, Rabab El-SAYED, Hemat ALI

Abstract


Background: Curcumin is the major active ingredient of Curcuma longa L., traditionally known as turmeric and has been shown to exhibit a wide range of pharmacological activities including anti-parasitic effect. However, it is found to be water-insoluble and has low bioavailability. The aim of this study was to explore the potential role of turmeric solved in olive oil either alone or in combination with praziquantel (PZQ) in treatment of schistosomiasis mansoni.

Methods: The whole turmeric powder suspended in olive oil (as a solvent) is indicated to S. mansoni-infected mice aiming to study its potential therapeutic role, either alone or in combination with PZQ.

Results: Turmeric significantly reduced S. mansoni worm burden and complete absence of adult worms achieved in mice treated with combination of turmeric and PZQ. Turmeric has slight non-significant effect on the oogram pattern in all examined S. mansoni infected mice. Turmeric and PZQ found to exert a significant reduction of granuloma size in comparison with control. However, turmeric has a non-significant effect on granuloma number. On the other hand, turmeric or/and PZQ treated mice showed obvious improvement of pathology with mild cloudy swelling and less hydropic degeneration.

Conclusion: Turmeric significantly reduced parasite worm burden, granuloma size and consequently the pathology of affected liver, it still far less effective than PZQ.

Keywords


Turmeric; Schistosoma mansoni; Praziquantel

Full Text:

PDF

References


Lustigman S, Prichard RK, Gazzinelli A et al. A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis. 2012; 6(4):e1582.

Wang W, Wang L, Liang YS. Susceptibility or resistance of PZQ in human schistosomiasis: a review. Parasitol Res. 2012;111(5):1871-7.

Al-Sayed E, Hamid HA, Abu El Einin HM. Molluscicidal and antischistosomal activities of methanol extracts and isolated compounds from Eucalyptus globulus and Melaleuca styphelioides. Pharm Biol. 2014;52(6):698-705.

de Melo NI, Mantovani AL, de Oliveira PF et al. Antischistosomal and Cytotoxic Effects of the Essential Oil of Tetradenia riparia (Lamiaceae). Nat Prod Commun. 2015;10(9):1627-30.

Wakabayashi KA, de Melo NI, Aguiar DP et al. Anthelmintic effects of the essential oil of fennel (Foeniculum vulgare Mill., Apiaceae) against Schistosoma mansoni. Chem Biodivers. 2015;12(7):1105-14.

Maheshwari RK, Singh AK, Gaddipati J et al. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081-7.

Nose M, Koide T, Ogihara Y et al. Trypanocidal effects of curcumin in vitro. Biol Pharm Bull. 1998;21(6):643-5.

Pérez-Arriaga L, Mendoza-Magaña ML, Cortés-Zárate R et al. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Trop. 2006;98(2):152-61.

Cheikh-Ali Z, Caron J, Cojean S et al. "Squalenoyl curcumin" nanoassemblies as water-dispersible drug candidates with anti-leishmanial activity. Chem Med Chem. 2015; 10:411-418.

El-Ansary AK, Ahmed SA, Aly SA. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice. Indian J Exp Biol. 2007;45(9):791-801.

El-Banhawey MA, Ashry MA, El-Ansary AK et al. Effect of Curcuma longa or PZQ on Schistosoma mansoni infected mice liver—histological and histochemical study. Indian J Exp Biol. 2007;45(10):877-89.

Magalhães LG, Machado CB, Morais ER et al. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res. 2009;104(5):1197-201.

Allam G. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology. 2009;214(8):712-27.

El-Agamy DS, Shebl AM, Said SA. Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice. Inflammopharmacology. 2011;19(6):307-16.

Wahlström B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). 1978;43(2):86-92.

Begum AN, Jones MR, Lim GP et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease. J Pharmacol Exp Ther. 2008;326(1):196-208.

Antony B, Merina B, Iyer VS et al. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008;70(4):445-9.

Nessim NG, Demerdash Z. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with PZQ on murine schistosomiasis mansoni. Arzneimittelforschung. 2000; 50(2):173-7.

Duvall RH, DeWitt WB. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg. 1967;16(4):483-6.

Pellegrino J, Oliveira Ca, Faria J et al. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg. 1962;11:201-15.

Cançado JR, da Cunha AS, Carvalho DG DE et al. Evaluation of the treatment of human Schistosoma mansoni infection by the quantitative oogram technique. Bull World Health Organ. 1965;33(4):557-66.

von LICHTENBERG. Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am J Pathol. 1962;41:711-31.

Harris HR. On the rapid conversion of haematoxylin into haematein in staining reactions. J Appl Microsc. 1900; 3:777-780.

Masson P. Some histological methods, trichrome staining and their preliminary technique. Bull Int Ass Med. 1929; 12:75.

Botros S, El-Badawy N, Metwally AA et al. Studies of some immunological properties of PZQ in experimental schistosomiasis mansoni. Ann Trop Med Parasitol. 1986; 80:189-96.

Mahmoud AA, Warren KS. Anti-inflammatory effects of tartar emetic and niridazole suppression of Schistosoma egg granuloma. J Immunol. 1974;112(1):222-8.

Anand P, Kunnumakkara AB, Newman RA et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-18.

Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2012;17(1-2):71-80.

EL-Sherbiny M, Abdel-Aziz MM, Elbakry KA et al. Schistosomicidal effect of curcumin. Trends Appl Sci Res. 2010; 1:627-633.

Kamal RO. A considerable curative effect of the combined dose of curcumin and artemether on the early infection of Schistosoma mansoni in mice. Egypt J Zool. 2010; 55:101-118.

Pan MH, Huang TM, Lin JK. Biotransfor-mation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 1999;27(4):486-94.

Faust EC, Jones CA, Hoffman WA. Studies on schistosomiasis mansoni in Puerto Rico. III - Biological studies. 2. The mammalian phase of the life cycle. PR J Public Health Trop Med. 1934; 10:133-196.

El-Missiry AG, El-Nahal HS, Metwally AA et al. Experimental schistosomiasis mansoni: Efficacy of Ro 15-5458 hoffmann-la roache on different intensities of infections. New Egypt J Med. 1996; 15:257-261.

Wasilewski MM, Lim KC, Phillips J et al. Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden an egg production in vivo. Mol Biochem Parasitol. 1996;81(2):179-89.

Metwally A, Abdel-Hadi A, Mikail GE et al. Study of efficacy of the new antischistosomal drug 10-12 (Diethyl-amino) ethyl 7-9-acridanone-(thiazolidine) hydrazine against an Egyptian strain of S. mansoni in mice. Arzeim-Forsch/Drug Res. 1997; 47:975-979.

Issa RM. Schistosoma mansoni: The prophylactic and curative effects of propolis in experimentally-infected mice. Rawal Med J. 2007; 32:94-98.

El-Sisi A, Awara W, El-Masry T. Effects and mechanism of action of immunomodulating agents against schistosomiasis-induced hepatic inflammation and fibrosis in mice. Res Pharm Biotech. 2011; 3:32-45.

Andrade ZA, Cheever AW. Characterization of the murine model of schistosomal hepatic periportal fibrosis ("pipestem" fibrosis). Int J Exp Pathol. 1993;74(2):195-202.

Warren KS, Domingo EO, Cowan RB. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol. 1967;51(5):735-56.

Waiganjo N, Yole D, Ochanda H. Anti-Schistosomal activity of five plant extracts on Swiss white mice infected with Schistosoma mansoni. IOSR-JPBS. 2014; 9(1):49-53.

Yadav VS, Mishra KP, Singh DP et al. Im-munomodulatory effects of curcumin. Im-munopharmacol Immunotoxicol. 2005; 27(3):485-97.

Sharma S, Chopra K, Kulkarni SK et al. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol. 2007;147(1):155-63.

Wynn TA, Eltoum I, Cheever AW et al. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol. 1993; 151(3):1430-40.

Bourke CD, Nausch N, Rujeni N et al. Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarization following treatment of human schistosomiasis. J Infect Dis. 2013;208(1):159-69.

Jain SK, Rains J, Croad J et al. Curcumin supplementation lowers TNFα, IL6, IL8, and MCP1 secretion in high glucose-treated cultured monocytes and blood levels of TNFα, IL6, MCP1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 2009; 11:241–249.

El-Lakkany NM, Hammam OA, El-Maadawy WH et al. Anti-inflammatory/antifibrotic effects of the hepatoprotective silymarin and the schistosomicide PZQ against Schistosoma mansoni induced liver fibrosis. Parasit Vec-tors. 2012; 5:9.

Seif El-Din SH, Abdel-Aal Sabra AN, Hammam OA et al. Effect of Ketoconazole, a Cytochrome P450 Inhibitor, on the Efficacy of Quinine and Halofantrine against Schistosoma mansoni in Mice. Korean J Parasitol. 2013;51(2):165-75.

El-Aasar AA, Merzabani MM, Zakhary NI et al. Biochemical and biophysical studies on schistosomal liver of mice. Egypt J Bilha. 1989; 11:19.

Gerges FR, Haroun NH, El-Nahal HMS et al. Effect of PZQ administration on infected albino mice with Schistosoma mansoni. Egypt J Bilh. 1994; 16:157-171.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.